CC
AMED

Centiva Capital’s Amedisys AMED Stock Holding History

Centiva Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-135,917
Closed -$13.4M – 1070
2025
Q2 		$13.4M Buy
135,917
+67,244
+98% +$6.36M 0.22% 67
2025
Q1 		$6.36M Sell
68,673
-41,567
-38% -$3.83M 0.19% 47
2024
Q4 		$10M Buy
110,240
+19,881
+22% +$1.83M 0.21% 48
2024
Q3 		$8.72M Buy
90,359
+64,233
+246% +$6.27M 0.17% 99
2024
Q2 		$2.4M Buy
26,126
+13,065
+100% +$1.21M 0.04% 330
2024
Q1 		$1.2M Sell
13,061
-2,006
-13% -$188K 0.03% 570
2023
Q4 		$1.43M Sell
15,067
-47,433
-76% -$4.43M 0.03% 462
2023
Q3 		$5.84M Buy
62,500
+47,500
+317% +$4.39M 0.13% 140
2023
Q2 		$1.37M Buy
+15,000
New +$1.23M 0.03% 491
2021
Q4 		– Sell
-2,721
Closed -$406K – 1167
2021
Q3 		$406K Buy
2,721
+1,600
+143% +$333K 0.03% 691
2021
Q2 		$275K Buy
+1,121
New +$294K 0.01% 1080

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Centiva Capital's AMED Position: Q3 2025 in Review

Centiva Capital sold out of Amedisys (AMED) in Q3 2025, closing a stake of 135,917 shares — an estimated $13.4M sold.

Centiva Capital first reported a position in AMED in Q2 2021 and held it in 11 quarters. The position peaked at $13.4M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Centiva Capital reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 135,917 Amedisys shares in Q3 2025, an estimated $13.4M.
  • Centiva Capital first reported a position in Amedisys in Q2 2021 and held it in 11 quarters.
  • Centiva Capital's Amedisys position peaked at $13.4M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.